We are live on ! Find out more
ABBV icon

AbbVie
ABBV

1,286 hedge funds and large institutions have $44.6B invested in AbbVie in 2013 Q2 according to their latest regulatory filings, with 1,286 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.14% more ownership

Funds ownership: 0% → 68.14% (+68%)

33% more call options, than puts

Call options by funds: $182M | Put options by funds: $137M

Holders
1,286
Holders Change
+1,286
Holders Change %
–
% of All Funds
41.97%
Holding in Top 10
39
Holding in Top 10 Change
+39
Holding in Top 10 Change %
% of All Funds
1.27%
New
1,286
Increased
–
Reduced
–
Closed
–
Calls
$182M
Puts
$137M
Net Calls
+$45.2M
Net Calls Change
+$45.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DWT
901
Dorsey & Whitney Trust
South Dakota
$828K +$876K +20,024 New
DCM
902
Dinsmore Capital Management
New Jersey
$827K +$875K +20,000 New
IPRC
903
Indices-Pac Research Corporation
New Jersey
$827K +$875K +20,006 New
HCA
904
Horan Capital Advisors
Ohio
$826K +$874K +19,992 New
BHBT
905
Burke & Herbert Bank & Trust
Virginia
$825K +$872K +19,935 New
DDC
906
DF Dent & Co
Maryland
$825K +$872K +19,947 New
LIC
907
Lodestar Investment Counsel
Illinois
$824K +$871K +19,921 New
SACTSONJ
908
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$821K +$868K +19,849 New
IAS
909
IMA Advisory Services
Colorado
$818K +$865K +19,786 New
CIM
910
CIM Investment Management
Pennsylvania
$817K +$865K +19,775 New
ACM
911
Avalon Capital Management
California
$813K +$860K +19,671 New
PP
912
Patten & Patten
Tennessee
$812K +$859K +19,633 New
CNBT
913
Canandaigua National Bank & Trust
New York
$809K +$856K +19,572 New
PFM
914
PacWest Financial Management
Arizona
$806K +$852K +19,490 New
FAAM
915
First Allied Asset Management
California
$805K +$847K +19,374 New
WS
916
Wedbush Securities
California
$803K +$849K +19,420 New
NIC
917
Northwest Investment Counselors
Oregon
$797K +$843K +19,277 New
SAG
918
Sterne Agee Group
Alabama
$797K +$843K +19,277 New
NCM
919
Narwhal Capital Management
Georgia
$796K +$842K +19,250 New
RRWJ
920
R. Robert Woodburn Jr
$796K +$842K +19,261 New
HSA
921
HBK Sorce Advisory
Pennsylvania
$792K +$839K +19,178 New
GLI
922
Guardian Life Insurance
New York
$786K +$832K +19,022 New
PFC
923
Poplar Forest Capital
California
$785K +$831K +18,990 New
CAM
924
Congress Asset Management
Massachusetts
$784K +$829K +18,953 New
CCA
925
Cobblestone Capital Advisors
New York
$784K +$830K +18,975 New
35 36
37
38 39

ABBV Hedge Fund Activity: Q2 2013 in Review

1,286 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2013, worth a combined $44.6B.

Buyers outnumbered sellers: 1,286 funds opened new ABBV positions and 0 closed out — a net gain of 1,286 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,286 institutional investors held AbbVie (ABBV) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $44.6B of AbbVie stock for Q2 2013.
  • 1,286 funds opened new AbbVie positions in Q2 2013 and 0 closed out, a net change of +1,286 holders.

Based on aggregated 13F filings for Q2 2013.